Vaccine

Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth

1 month ago

Moderna Inc. (NASDAQ: MRNA) reported fourth-quarter 2025 revenue of $678 million, a 30% decrease from $966 million in the same…